These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 15915352

  • 1. Effect of probenecid on the pharmacokinetics of carbamazepine in healthy subjects.
    Kim KA, Oh SO, Park PW, Park JY.
    Eur J Clin Pharmacol; 2005 Jun; 61(4):275-80. PubMed ID: 15915352
    [Abstract] [Full Text] [Related]

  • 2. Effect of Piperine on the Metabolism and Pharmacokinetics of Carbamazepine in Healthy Volunteers.
    Bedada SK, Appani R, Boga PK.
    Drug Res (Stuttg); 2017 Jan; 67(1):46-51. PubMed ID: 27776366
    [Abstract] [Full Text] [Related]

  • 3. A comparative pharmacokinetic study in healthy volunteers of the effect of carbamazepine and oxcarbazepine on cyp3a4.
    Andreasen AH, Brøsen K, Damkier P.
    Epilepsia; 2007 Mar; 48(3):490-6. PubMed ID: 17346248
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Pharmacokinetic interaction study between the new antiepileptic and CNS drug RWJ-333369 and carbamazepine in healthy adults.
    Chien S, Bialer M, Solanki B, Verhaeghe T, Doose DR, Novak G, Yao C.
    Epilepsia; 2006 Nov; 47(11):1830-40. PubMed ID: 17116022
    [Abstract] [Full Text] [Related]

  • 6. Pharmacokinetic and metabolic investigation of topiramate disposition in healthy subjects in the absence and in the presence of enzyme induction by carbamazepine.
    Britzi M, Perucca E, Soback S, Levy RH, Fattore C, Crema F, Gatti G, Doose DR, Maryanoff BE, Bialer M.
    Epilepsia; 2005 Mar; 46(3):378-84. PubMed ID: 15730535
    [Abstract] [Full Text] [Related]

  • 7. The effects of probenecid on the disposition of risperidone and olanzapine in healthy volunteers.
    Markowitz JS, Devane CL, Liston HL, Boulton DW, Risch SC.
    Clin Pharmacol Ther; 2002 Jan; 71(1):30-8. PubMed ID: 11823755
    [Abstract] [Full Text] [Related]

  • 8. Effect of resveratrol on the pharmacokinetics of carbamazepine in healthy human volunteers.
    Bedada SK, Nearati P.
    Phytother Res; 2015 May; 29(5):701-6. PubMed ID: 25624269
    [Abstract] [Full Text] [Related]

  • 9. Modulation of CYP3A enzyme activity by diosmin and its consequence on carbamazepine pharmacokinetics in rats.
    Bedada SK, Neerati P.
    Naunyn Schmiedebergs Arch Pharmacol; 2018 Feb; 391(2):115-121. PubMed ID: 29134244
    [Abstract] [Full Text] [Related]

  • 10. Effects of sinapic acid on hepatic cytochrome P450 3A2, 2C11, and intestinal P-glycoprotein on the pharmacokinetics of oral carbamazepine in rats: Potential food/herb-drug interaction.
    Raish M, Ahmad A, Ansari MA, Alkharfy KM, Ahad A, Al-Jenoobi FI, Al-Mohizea AM, Khan A, Ali N.
    Epilepsy Res; 2019 Jul; 153():14-18. PubMed ID: 30927680
    [Abstract] [Full Text] [Related]

  • 11. Influence of diosmin on the metabolism and disposition of carbamazepine in healthy subjects.
    Bedada SK, Boga PK.
    Xenobiotica; 2017 Oct; 47(10):879-884. PubMed ID: 27690733
    [Abstract] [Full Text] [Related]

  • 12. Pharmacokinetic interaction between efavirenz and carbamazepine after multiple-dose administration in healthy subjects.
    Ji P, Damle B, Xie J, Unger SE, Grasela DM, Kaul S.
    J Clin Pharmacol; 2008 Aug; 48(8):948-56. PubMed ID: 18519918
    [Abstract] [Full Text] [Related]

  • 13. Serum carbamazepine concentrations in elderly patients: a case-matched pharmacokinetic evaluation based on therapeutic drug monitoring data.
    Battino D, Croci D, Rossini A, Messina S, Mamoli D, Perucca E.
    Epilepsia; 2003 Jul; 44(7):923-9. PubMed ID: 12823575
    [Abstract] [Full Text] [Related]

  • 14. Lack of interaction between HEPP, a new antiepileptic agent, and carbamazepine in rabbits.
    García AL, Medina RL, Pérez MR, Jung CH.
    Biopharm Drug Dispos; 2003 Jul; 24(5):205-9. PubMed ID: 12784320
    [Abstract] [Full Text] [Related]

  • 15. Telithromycin, but not montelukast, increases the plasma concentrations and effects of the cytochrome P450 3A4 and 2C8 substrate repaglinide.
    Kajosaari LI, Niemi M, Backman JT, Neuvonen PJ.
    Clin Pharmacol Ther; 2006 Mar; 79(3):231-42. PubMed ID: 16513447
    [Abstract] [Full Text] [Related]

  • 16. A limited sampling method for the estimation of AUC and Cmax of carbamazepine and carbamazepine epoxide following a single and multiple dose of a sustained-release product.
    Mahmood I, Chamberlin N.
    Br J Clin Pharmacol; 1998 Mar; 45(3):241-6. PubMed ID: 9517367
    [Abstract] [Full Text] [Related]

  • 17. Effects of Paeonia emodi on hepatic cytochrome P450 (CYP3A2 and CYP2C11) expression and pharmacokinetics of carbamazepine in rats.
    Raish M, Ahmad A, Alkharfy KM, Jan BL, Mohsin K, Ahad A, Al-Jenoobi FI, Al-Mohizea AM.
    Biomed Pharmacother; 2017 Jun; 90():694-698. PubMed ID: 28419964
    [Abstract] [Full Text] [Related]

  • 18. Pioglitazone, an in vitro inhibitor of CYP2C8 and CYP3A4, does not increase the plasma concentrations of the CYP2C8 and CYP3A4 substrate repaglinide.
    Kajosaari LI, Jaakkola T, Neuvonen PJ, Backman JT.
    Eur J Clin Pharmacol; 2006 Mar; 62(3):217-23. PubMed ID: 16447051
    [Abstract] [Full Text] [Related]

  • 19. Effect of valpromide on the pharmacokinetics of carbamazepine-10, 11-epoxide.
    Pisani F, Fazio A, Oteri G, Spina E, Perucca E, Bertilsson L.
    Br J Clin Pharmacol; 1988 May; 25(5):611-3. PubMed ID: 3136790
    [Abstract] [Full Text] [Related]

  • 20. Effects of short-term lamotrigine treatment on pharmacokinetics of carbamazepine.
    Malminiemi K, Keränen T, Kerttula T, Moilanen E, Ylitalo P.
    Int J Clin Pharmacol Ther; 2000 Nov; 38(11):540-5. PubMed ID: 11097146
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.